{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:22:52Z","timestamp":1790882572434,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Infections caused by Cryptococcus gattii mainly affect immunocompetent individuals and the treatment presents important limitations. This study aimed to validate the efficacy of selective serotonin reuptake inhibitors (SSRI), fluoxetine hydrochloride (FLH), and paroxetine hydrochloride (PAH) in vitro against C. gattii. The antifungal activity of SSRI using the microdilution method revealed a minimal inhibitory concentration (MIC) of 31.25\u00a0\u00b5g\/ml. The combination of FLH or PAH with amphotericin B (AmB) was analyzed using the checkerboard assay and the synergistic effect of SSRI in combination with AmB was able to reduce the SSRI or AmB MIC values 4\u20138-fold. When examining the effect of SSRI on the induced capsules, we observed that FLH and PAH significantly decreased the size of C. gattii capsules. In addition, the effects of FLH and PAH were evaluated in biofilm biomass and viability. The SSRI were able to reduce biofilm biomass and biofilm viability. In conclusion, our results indicate the use of FLH and PAH exhibited in vitro anticryptococcal activity, representing a possible future alternative for the cryptococcosis treatment.<\/jats:p>","DOI":"10.1093\/femspd\/ftae001","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T05:53:19Z","timestamp":1704952399000},"source":"Crossref","is-referenced-by-count":2,"title":["<i>In vitro<\/i> effects of selective serotonin reuptake inhibitors on <i>Cryptococcus gattii<\/i> capsule and biofilm"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4738-7041","authenticated-orcid":false,"given":"Let\u00edcia Rampazzo da Gama","family":"Viveiro","sequence":"first","affiliation":[{"name":"Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, S\u00e3o Paulo State University (UNESP) , S\u00e3o Paulo 12245-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Rodrigues","family":"Rehem","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, S\u00e3o Paulo State University (UNESP) , S\u00e3o Paulo 12245-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn Luzia De Souza","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, S\u00e3o Paulo State University (UNESP) , S\u00e3o Paulo 12245-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Henrique Fonseca do","family":"Carmo","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, S\u00e3o Paulo State University (UNESP) , S\u00e3o Paulo 12245-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-6856","authenticated-orcid":false,"given":"Juliana Campos","family":"Junqueira","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, S\u00e3o Paulo State University (UNESP) , S\u00e3o Paulo 12245-000 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Scorzoni","sequence":"additional","affiliation":[{"name":"Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, S\u00e3o Paulo State University (UNESP) , S\u00e3o Paulo 12245-000 ,","place":["Brazil"]},{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Enfermagem, Universidade de Guarulhos , Guarulhos, S\u00e3o Paulo 07023-070 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"2024121400005580500_bib1","first-page":"1","article-title":"Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts","volume-title":"EUCAST DEFINITIVE DOCUMENT E.DEF 7.3.1","author":"Arendrup","year":"2017"},{"key":"2024121400005580500_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.micpath.2017.04.008","article-title":"In vitro anti-Candida activity of selective serotonin reuptake inhibitors against fluconazole-resistant strains and their activity against biofilm-forming isolates","volume":"107","author":"Costa\u00a0Silva","year":"2017","journal-title":"Microb Pathog"},{"key":"2024121400005580500_bib3","first-page":"28","article-title":"Antidepressant drugs: prevalence, profile and knowledge of the user population","volume":"2","author":"Cruz","year":"2020","journal-title":"Braz J Health Pharm"},{"key":"2024121400005580500_bib4","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1038\/s41467-022-32249-5","article-title":"The importance of antimicrobial resistance in medical mycology","volume":"13","author":"Gow","year":"2022","journal-title":"Nat Commun"},{"key":"2024121400005580500_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fmicb.2017.00535","article-title":"The anti-helminthic compound mebendazole has multiple antifungal effects against cryptococcus neoformans","volume":"8","author":"Joffe","year":"2017","journal-title":"Front Microbiol"},{"key":"2024121400005580500_bib6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/14656566.2016.1186647","article-title":"Can repurposing of existing drugs provide more effective therapies for invasive fungal infections?","volume":"17","author":"Katragkou","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"2024121400005580500_bib7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/48.6.775","article-title":"Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro","volume":"48","author":"Lass-Florl","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"2024121400005580500_bib8","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neuropharm.2004.06.033","article-title":"Modulation of memory processes and cellular excitability in the dentate gyrus of freely moving rats by a 5-HT4 receptors partial agonist, and an antagonist","volume":"47","author":"Marchetti","year":"2004","journal-title":"Neuropharmacology"},{"key":"2024121400005580500_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/AAC.50.3.1021-1033.2006","article-title":"Susceptibility of cryptococcus neoformans biofilms to antifungal agents In vitro","volume":"50","author":"Martinez","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2024121400005580500_bib10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S2215-0366(21)00154-1","article-title":"The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action","volume":"8","author":"Murphy","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"2024121400005580500_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2024121400005580500_bib12","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1128\/AAC.02623-13","article-title":"Anti-Candida activity of fluoxetine alone and combined with fluconazole: a synergistic action against fluconazole-resistant strains","volume":"58","author":"Oliveira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2024121400005580500_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00430-018-0539-0","article-title":"Anti-Candida activity of antidepressants sertraline and fluoxetine: effect upon pre-formed biofilms","volume":"207","author":"Oliveira","year":"2018","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"2024121400005580500_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mimet.2007.11.010","article-title":"Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates","volume":"72","author":"Peeters","year":"2008","journal-title":"J Microbiol Methods"},{"key":"2024121400005580500_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femspd\/ftab001","article-title":"In vitro synergistic effects of fluoxetine and paroxetine in combination with amphotericin B against Cryptococcus neoformans","volume":"79","author":"Pereira","year":"2021","journal-title":"Pathog Dis"},{"key":"2024121400005580500_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2024121400005580500_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2024121400005580500_bib18","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/AAC.47.11.3653-3656.2003","article-title":"G484S Amino acid substitution in lanosterol 14-\u03b1 demethylase (ERG11) is related to fluconazole resistance in a recurrent cryptococcus neoformans clinical isolate","volume":"47","author":"Rodero","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2024121400005580500_bib19","doi-asserted-by":"crossref","first-page":"e0007964","DOI":"10.1371\/journal.pntd.0007964","article-title":"Fungal diseases as neglected pathogens: a wake-up call to public health officials","volume":"14","author":"Rodrigues","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2024121400005580500_bib20","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1017\/S143192761601117X","article-title":"ImageJ: image analysis interoperability for the next generation of biological image data","volume":"22","author":"Rueden","year":"2016","journal-title":"Microsc Microanal"},{"key":"2024121400005580500_bib21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice Guidelines for the management of Cryptococcal disease","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2024121400005580500_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.00036","article-title":"Antifungal therapy: new advances in the understanding and treatment of mycosis","volume":"08","author":"Scorzoni","year":"2017","journal-title":"Front Microbiol"},{"key":"2024121400005580500_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/21505594.2016.1196300","article-title":"Combinatorial strategies for combating invasive fungal infections","volume":"8","author":"Spitzer","year":"2017","journal-title":"Virulence"},{"key":"2024121400005580500_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3201\/eid1601.090369","article-title":"Projecting global occurrence of cryptococcus gattii","volume":"16","author":"Springer","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"2024121400005580500_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/mmy\/myv109","article-title":"Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays","volume":"54","author":"Trevi\u00f1o-Rangel","year":"2016","journal-title":"Med Mycol"},{"key":"2024121400005580500_bib26","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2217\/fmb.13.84","article-title":"Elucidating the immunological function of the Cryptococcus neoformans capsule","volume":"8","author":"Vecchiarelli","year":"2013","journal-title":"Future Microbiol"},{"key":"2024121400005580500_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1251\/bpo68","article-title":"Experimental modulation of capsule size in Cryptococcus neoformans","volume":"6","author":"Zaragoza","year":"2004","journal-title":"Biol Proced Online"},{"key":"2024121400005580500_bib28","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/j.1462-5822.2008.01186.x","article-title":"Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival","volume":"10","author":"Zaragoza","year":"2008","journal-title":"Cell Microbiol"},{"key":"2024121400005580500_bib29","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pathogens and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/femspd\/advance-article-pdf\/doi\/10.1093\/femspd\/ftae001\/55403721\/ftae001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femspd\/article-pdf\/doi\/10.1093\/femspd\/ftae001\/61155047\/ftae001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femspd\/article-pdf\/doi\/10.1093\/femspd\/ftae001\/61155047\/ftae001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:01:23Z","timestamp":1734134483000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article\/doi\/10.1093\/femspd\/ftae001\/7515272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":29,"URL":"https:\/\/doi.org\/10.1093\/femspd\/ftae001","relation":{},"ISSN":["2049-632X"],"issn-type":[{"value":"2049-632X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]},"article-number":"ftae001"}}